AMERISOURCEBERGEN
17.11.2022 14:31:38 CET | Business Wire | Press release
Alliance Healthcare, a part of global healthcare company AmerisourceBergen and a leading wholesaler of pharmaceutical products in Europe, and GIRP, the European Healthcare Distribution Association, convened policymakers and leaders across the healthcare and pharmaceutical industries today to discuss antimicrobial resistance (AMR), examine current response efforts and explore opportunities to collaborate on initiatives to combat the global public health issue.
The inaugural event featured remarks from members of the European Parliament, European Commission and organizations spearheading AMR response efforts, as well as panel discussions led by healthcare and pharmaceutical executives. Panelists and speakers covered a variety of topics, including how public policy can advance response efforts, strategies to increase awareness of AMR, actions healthcare providers are taking to combat resistance, and public-private partnerships to support the development of new antimicrobials. Professor Dame Sally Davies, UK Special Envoy on AMR and member of the UN Global Leaders Group on AMR, delivered a keynote address focused on mobilizing international efforts and driving a global response.
AMR, which occurs when a microorganism (bacteria, virus, fungi, parasite) develops the ability to resist the effects of a drug, is a significant global public health threat. The World Health Organization (WHO), U.S. Government and European Commission each have initiated action plans against AMR.
“Addressing an issue as complex and far-reaching as AMR requires public-private collaboration and coordination across multiple sectors,” said Gianluigi Tassone, President of Alliance Healthcare. “By hosting this event, we sought to bring together policymakers, leaders across the healthcare supply chain and those at the forefront of international response efforts to discuss current approaches, share best practices and identify opportunities in which we can work together to help address this issue.”
“As the EU outlined in its action plan, there is an urgent need for multi-sector collaboration, innovation and policy action to tackle AMR,” said Monika Derecque-Pois, Director General of GIRP. “While this event serves as an important step in bringing together leaders across different industries, it’s equally important we continue these conversations and build on the potential solutions discussed today to help drive meaningful, sustained change.”
During the provider-focused panel, leaders from the European Hospital and Healthcare Federation, Standing Committee of European Doctors, European Association of Hospital Pharmacists and Boots UK offered perspective on how healthcare systems across Europe are prepared to manage AMR. The panelists spoke to the actions needed to combat resistance, including infection prevention and control measures, and initiatives underway to educate patients on AMR. For example, Alphega Pharmacy, a pan-European network of independent pharmacists and a part of Alliance Healthcare, launched a campaign to drive awareness of AMR and provide patients with additional counseling and education on proper use of antibiotics.
Representatives from the AMR Action Fund, a public-private partnership investing in biotech companies that are developing antibiotics, and BEAM Alliance, a coalition of small and medium-sized biopharma companies in Europe involved in developing products to combat AMR, discussed current industry priorities, including innovative approaches to support the research and development of new antibiotics and sustainable models to improve access to new antibiotics, diagnostics and vaccines globally.
“AMR is a silent pandemic. No one player can solve it on their own – it demands a coordinated approach,” said Dame Sally. “By collaborating across sectors and countries, we can innovate to secure the future of modern medicine so that treatments can be used sustainably by all who need them.”
About AmerisourceBergen
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies, and providers, we create unparalleled access, efficiency, and reliability for human and animal health. Our more than 43,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at https://amerisourcebergen.com/.
European Healthcare Distribution Association (GIRP)
GIRP, the European Healthcare Distribution Association, is the umbrella organisation for full-service healthcare distributors in Europe. It represents the national associations of over 750 pharmaceutical wholesalers serving 34 European countries, as well as major international and pan-European healthcare distribution companies. GIRP members employ over 140,000 people and distribute around 15 billion packs of medicines as well as a wide range of healthcare products per year. As the vital link in healthcare, they are committed to developing and providing innovative and efficient healthcare products and services to improve health and wellbeing of patients across Europe. Learn more at girp.eu.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221117005239/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Accertify's Q2 Global Air Travel Fraud Report Finds Fraud Pressure Intensifying Across Middle East and Africa15.7.2026 13:00:00 CEST | Press release
Analysis of nearly 133 million airline booking transactions finds bookings departing from Cairo carried the world's highest fraud rate this quarter, while departure cities across the United States and Australia posted among the lowest fraud rates Accertify, a leading fraud decisioning provider whose Predictive Yes Platform helps merchants say yes to more good customers, more revenue, and more growth, today announced the release of its Global Air Travel Fraud Report: Q2 2026, a quarterly analysis examining how fraud pressure varies across global airline markets based on departure city at time of booking. Based on analysis of 132.9 million airline booking transactions processed between April and June 2026, the report evaluates prevented fraud rates across 537 departure cities that each processed at least 10,000 transactions during the quarter, providing airlines with a data-driven view of where Accertify's Predictive Yes platform intervened most frequently at booking. The Q2 findings rev
Forrester’s 2027 Budget Planning Guides: After A Year Of Caution, Business And Tech Leaders Are Ready To Invest Again15.7.2026 11:00:00 CEST | Press release
While leaders are betting on growth, in the age of AI, spending more is no longer enough According to Forrester’s (Nasdaq: FORR) 2027 Budget Planning Guides, business and technology leaders are approaching 2027 with renewed confidence as they increasingly accept volatility as a permanent feature of the business environment. After a year of more cautious spending, more than 80% of leaders expect their budgets to increase over the next 12 months, with as many as one-quarter anticipating growth of 10% or more. But planning in the age of AI demands more than bigger budgets: Increasing investment without modernizing operating models, strengthening data foundations, and improving AI readiness will only accelerate fragmented data, duplicated work, and technical debt. To realize AI’s full potential, leaders must rethink their strategies and prioritize investments in operational foundations, governance, and experimentation that drive tangible outcomes. This year, optimism is widespread across f
Post-Quantum’s Algorithm - Classic McEliece - Achieves Global ISO Standardization to Protect the World From Quantum Cyber Attack15.7.2026 10:00:00 CEST | Press release
Ultra-secure encryption algorithm added to ISO standard for Asymmetric Ciphers Classic McEliece is first PQC algorithm to achieve global standardization Organisations in 177 ISO member states can now adopt Classic McEliece to remain secure from attack by both classical and quantum computers Governments including Germany and the Netherlands already recommend the highly secure Classic McEliece algorithm due to its unmatched security credentials It’s proven that today’s encryption is vulnerable to attack by a sufficiently mature quantum computer running Shor’s algorithm - a catastrophic event commonly known as Q-Day. Even before such a cryptographically relevant quantum computer emerges it is known that adversaries are stealing encrypted data now, which can be decrypted later - also known as Harvest Now, Decrypt Later (HNDL). Google’s recent use of Artificial Intelligence (AI) to optimise Shor’s algorithm reduces the number of physical qubits required to break today’s encryption, therefor
Thredd Joins The Visa Agentic Ready Programme, Bringing Agent Network Readiness To Issuers Across Europe, Starting With Zilch15.7.2026 09:00:00 CEST | Press release
Thredd, the AI-first issuer processing platform, today announced it has joined the Visa Agentic Ready programme, enabling issuers across Europe to participate in agent-initiated payments without rebuilding their payments infrastructure. Consumer payments platform Zilch will be among the first issuers on the platform to enable agent-initiated payments for its cardholders. As a processor and enabler, Thredd sits at the trust layer of the payments ecosystem. By joining the programme, Thredd is ready to support Visa and its clients as the market moves into agentic commerce. Agentic commerce introduces a new type of payment initiator: An AI agent acting on a cardholder's behalf. The core payments principles do not change. Cardholder permission, issuer approval, authentication and fraud monitoring all still apply. What changes is how trust is established and enforced at the point an agent transacts. Taking a Zilch customer as an example, a cardholder might ask an AI agent to find a product w
Surgerii Robotics Announces First European Installation of the SHURUI® Single-Port Surgical System at Vall d'Hebron University Hospital15.7.2026 09:00:00 CEST | Press release
Surgerii Robotics today announced the first European installation of its SHURUI Single-Port (SP) Surgical System at Vall d'Hebron University Hospital in Barcelona, Spain, one of Europe's leading academic medical centers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713209503/en/ The first pediatric procedure performed with the SHURUI SP system was a nephroureterectomy on a twelve-year-old boy whose kidney and ureter had become infected and non-functional due to multiple stones. The SHURUI SP system is CE-marked for adult and pediatric use, making it the only CE-marked single-port robotic surgical system currently indicated for pediatric procedures in Europe. The installation marks an important milestone in the international expansion of Surgerii Robotics and the introduction of the technology into a major European reference center. As part of this collaboration, Vall d'Hebron University Hospital has become the first hos
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom